ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633713; 2) Community: the network communities that were significantly associated with the response to NSC 633713; 3) Molecule: the relationships between components within communities and NSC 633713; 4) MDR: the compounds that were significantly associated with the NSC 633713.

NSC Compound Enrichment Correlation
NSC 728317 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}butane Bis(trifluoroacetate) 0.00888636978630782 0.3872957
NSC 757113 METHOTREXATE(+/-) 0.00888636978630782 0.75273123
NSC 9706 Triethylenemelamine 0.00888636978630782 0.53341982
NSC 107124 Camptothecin Derivative 0.00888636978630788 0.40340151
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.00888636978630788 0.52260584
NSC 134725 K-33 0.00888636978630788 0.46797719
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.00888636978630788 0.22370239
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.00888636978630788 0.56214117
NSC 264880 Dihydro-5-azacytidine 0.00888636978630788 0.19948302
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00888636978630788 0.45184291
Total:130  Current:38    [First] [Prev] [Next] [Last]